Monte Rosa Therapeutics Inc (GLUE) Insider Trading
- $58,400.00
- $11,579,604.72
- March 24, 2025
- Versant Venture Capital Vi, L.
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 24, 2025 | Director | 10,000 | $5.84 | Buy | $58,400.00 | |
| Oct. 28, 2024 | Major Shareholder | 89,990 | $9.66 | Sell | $869,303.40 | |
| Sept. 20, 2024 | Major Shareholder | 1,132,566 | $6.53 | Sell | $7,395,655.98 | |
| Sept. 13, 2024 | Major Shareholder | 9,269 | $6.16 | Sell | $57,097.04 | |
| Sept. 11, 2024 | Major Shareholder | 541,897 | $6.00 | Sell | $3,251,382.00 | |
| July 5, 2024 | Insider | 1,610 | $3.83 | Sell | $6,166.30 |
Insiders are both buying and selling Monte Rosa Therapeutics Inc stock.
The insider traders at Monte Rosa Therapeutics Inc are: Versant Venture Capital Vi, L., Chandra P Leo, and Edmund Dunn
The most active insider trader at Monte Rosa Therapeutics Inc is Versant Venture Capital Vi, L. with 4 trades.
Versant Venture Capital Vi, L. has sold the most Monte Rosa Therapeutics Inc stock with a total value of $12,442,741.82.
Chandra P Leo has bought the most Monte Rosa Therapeutics Inc stock with a total value of $116,800.00.
The most recent insider trade for Monte Rosa Therapeutics Inc was on March 24, 2025.
The single biggest insider buy for Monte Rosa Therapeutics Inc was from Chandra P Leo with a total value of $58,400.00 on March 24, 2025.
The single biggest insider sell for Monte Rosa Therapeutics Inc was from Versant Venture Capital Vi, L. with a total value of $7,395,655.98 on Sept. 20, 2024.